MYC and breast cancer: Transcriptome and immunoblot analyses demonstrated that miR-145 replacement induced the strong and dominant activation of IFN-STAT1/2 signaling and significant downregulation of c-Myc expression in BC cells, likely by both direct and IFN-STAT1/2-mediated indirect mechanisms.